Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Amandine Landemaine"'
Autor:
Nadia Fathallah, Laurent Siproudhis, Mélissa Akaffou, Mohamed Amine Haouari, Amandine Landemaine, Elise Pommaret, Lucas Spindler, Charlène Brochard, Guillaume Bouguen, Vincent Parades
Purpose: The aim of this study was to evaluate the real-life clinical and radiological efficacy of darvadstrocel injection into complex perianal fistulas in Crohn’s disease. Secondary endpoints were to assess symptomatic efficacy, outcomes and fact
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5f3ffeb13e7e3812f0d1e4f84191e0df
https://doi.org/10.21203/rs.3.rs-2619781/v1
https://doi.org/10.21203/rs.3.rs-2619781/v1
Autor:
Laurent Siproudhis, Eric Bellissant, Thomas Grainville, Guillaume Bouguen, Amandine Landemaine, Antoine Petitcollin, Eric Le Balch, Céline Miard, Marie Dewitte, Charlène Brochard
Publikováno v:
Clinical Gastroenterology and Hepatology
Clinical Gastroenterology and Hepatology, WB Saunders, 2021, 19 (2), pp.288-295.e4. ⟨10.1016/j.cgh.2020.03.018⟩
Clinical Gastroenterology and Hepatology, 2021, 19 (2), pp.288-295.e4. ⟨10.1016/j.cgh.2020.03.018⟩
Clinical Gastroenterology and Hepatology, WB Saunders, 2021, 19 (2), pp.288-295.e4. ⟨10.1016/j.cgh.2020.03.018⟩
Clinical Gastroenterology and Hepatology, 2021, 19 (2), pp.288-295.e4. ⟨10.1016/j.cgh.2020.03.018⟩
Background & Aims Infliximab increases the risk of infection in patients with inflammatory bowel diseases (IBD), but there is controversy over the relationship between drug concentration and infections. We aimed to assess factors associated with infe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ca646f1d9bad58568d8e62217093532
https://hal-univ-rennes1.archives-ouvertes.fr/hal-02533415
https://hal-univ-rennes1.archives-ouvertes.fr/hal-02533415
Autor:
Caroline de Kerguenec, Fabrice Laine, Séverine Cunat, Patricia Aguilar-Martinez, Xavier Causse, Lénaïck Détivaud, Bernard Drenou, Edouard Bardou-Jacquet, Gilles Pelletier, Olivier Loréal, Véronique Loustaud-Ratti, Houda Hamdi-Rozé, Yves Deugnier, Si Nafa Si Ahmed, Amandine Landemaine, Stéphane Durupt, Christophe Bureau, Martine Ropert, Nathalie Ganne-Carrié, Jeff Morcet
Publikováno v:
Journal of Hepatology
Journal of Hepatology, Elsevier, 2021, ⟨10.1016/j.jhep.2021.10.022⟩
Journal of Hepatology, 2022, 76 (3), pp.568-576. ⟨10.1016/j.jhep.2021.10.022⟩
Journal of Hepatology, Elsevier, 2021, ⟨10.1016/j.jhep.2021.10.022⟩
Journal of Hepatology, 2022, 76 (3), pp.568-576. ⟨10.1016/j.jhep.2021.10.022⟩
International audience; Background & aims - Ferroportin disease is a rare genetic iron overload disorder which may be underdiagnosed, with recent data suggesting it occurs at a higher prevalence than suspected. Costs and the lack of defined criteria
Autor:
Laurent Siproudhis, Amandine Landemaine, Eric Bellissant, Charlène Brochard, Antoine Petitcollin, Guillaume Bouguen, Camille Lucidarme, Marie Dewitte
Publikováno v:
Alimentary Pharmacology and Therapeutics
Alimentary Pharmacology and Therapeutics, 2019, 49 (2), pp.147-154. ⟨10.1111/apt.15046⟩
Alimentary Pharmacology and Therapeutics, Wiley, 2019, 49 (2), pp.147-154. ⟨10.1111/apt.15046⟩
Alimentary Pharmacology and Therapeutics, 2019, 49 (2), pp.147-154. ⟨10.1111/apt.15046⟩
Alimentary Pharmacology and Therapeutics, Wiley, 2019, 49 (2), pp.147-154. ⟨10.1111/apt.15046⟩
International audience; Background There are limited data concerning infliximab drug monitoring during de-escalation of the treatment of inflammatory bowel disease (IBD). Aim To define the rate and the predictors of relapse following infliximab de-es
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6f4f3577d998f2ea8a6c48b71185043
https://univ-rennes.hal.science/hal-01998041
https://univ-rennes.hal.science/hal-01998041
Autor:
Aurélien Garros, Laurent Siproudhis, Guillaume Bouguen, Amandine Landemaine, Alexandre Merlini l’Héritier, Tanguy Rohou, Charlène Brochard, Marie Dewitte, Belinda Tchoundjeu
Publikováno v:
Inflammatory Bowel Diseases
Inflammatory Bowel Diseases, Lippincott, Williams & Wilkins, 2018, 24 (7), pp.1612-1618. ⟨10.1093/ibd/izy055⟩
Inflammatory Bowel Diseases, 2018, 〈10.1093/ibd/izy055〉
Inflammatory Bowel Diseases, 2018, 24 (7), pp.1612-1618. ⟨10.1093/ibd/izy055⟩
Inflammatory Bowel Diseases, Lippincott, Williams & Wilkins, 2018, 24 (7), pp.1612-1618. ⟨10.1093/ibd/izy055⟩
Inflammatory Bowel Diseases, 2018, 〈10.1093/ibd/izy055〉
Inflammatory Bowel Diseases, 2018, 24 (7), pp.1612-1618. ⟨10.1093/ibd/izy055⟩
International audience; Background & aims - The European Crohn's and Colitis Organization recommends magnetic resonance imaging (MRI) of anal fistulas to decide on the drug/surgery strategy. No evidence is available on the long-term impact of MRI fea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd37c1990c5f0ae34f0313e95ac561e3
https://hal-univ-rennes1.archives-ouvertes.fr/hal-01807749
https://hal-univ-rennes1.archives-ouvertes.fr/hal-01807749
Autor:
Siproudhis Laurent, Charlène Brochard, Céline Miard, Guillaume Bouguen, Marie Dewitte, Antoine Petitcollin, Amandine Landemaine
Publikováno v:
Gastroenterology. 156:S-628